FDA has issued an RFI to solicit informal input regarding an End User Experience Monitoring solution for the U.S. Food and Drug Administration (FDA). “This solution would be used with the current mobile infrastructure to monitor the end user experience for mobile devices in the FDA portfolio. FDA mobile users utilize a variety of iOS and Samsung Android devices and there is a need for a product that monitors user interactions, device health and performance, and application performance. There are plans to expand device offerings to additional Android device types. FDA does not currently have a Bring Your Own Device (BYOD) program; all devices are government furnished equipment (GFE).”
Responses are due by March 21, 2018.
